loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

Genentech's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations aggregated by PharmaCompass

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 ADO-TRASTUZUMAB EMTANSINE (2)

02 ALTEPLASE (3)

03 ATEZOLIZUMAB (2)

04 BALOXAVIR MARBOXIL (4)

05 BEVACIZUMAB (2)

06 COBIMETINIB FUMARATE (1)

07 DORNASE ALFA (1)

08 EMICIZUMAB (4)

09 ENTRECTINIB (5)

10 FARICIMAB-SVOA (1)

11 GLOFITAMAB-GXBM (2)

12 MOSUNETUZUMAB-AXGB (2)

13 OBINUTUZUMAB (1)

14 OCRELIZUMAB (1)

15 OMALIZUMAB (4)

16 PERTUZUMAB (1)

17 PERTUZUMAB;TRASTUZUMAB;HYALURONIDASE-ZZXF (2)

18 PIRFENIDONE (4)

19 POLATUZUMAB VEDOTIN-PIIQ (2)

20 RANIBIZUMAB (2)

21 RISDIPLAM (1)

22 RITUXIMAB (2)

23 RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT) (2)

24 SATRALIZUMAB (1)

25 SOMATROPIN (8)

26 SOMATROPIN [rDNA origin] (1)

27 TENECTEPLASE (1)

28 TOCILIZUMAB (4)

29 TRASTUZUMAB (1)

30 TRASTUZUMAB; HYALURONIDASE-OYSK (1)

31 VISMODEGIB (1)

filter

01 GENENTECH (36)

02 GENENTECH INC (33)

filter

01 CAPSULE;ORAL (6)

02 FOR SOLUTION;ORAL (1)

03 FOR SUSPENSION;ORAL (1)

04 INJECTABLE; INJECTION (5)

05 INJECTABLE; INTRAVITREAL (1)

06 INJECTABLE;INJECTION (20)

07 INJECTABLE;INTRAVENOUS, SUBCUTANEOUS (1)

08 INJECTABLE;SUBCUTANEOUS (3)

09 Injectable; Injection (1)

10 PELLETS;ORAL (1)

11 POWDER;INTRAVENOUS (2)

12 SOLUTION;INJECTION (1)

13 SOLUTION;INTRAVENOUS (2)

14 SOLUTION;SUBCUTANEOUS (2)

15 SYRINGE (3)

16 TABLET;ORAL (7)

17 VIAL (4)

18 VIAL; INTRAVENOUS (3)

19 VIAL; SINGLE-USE (5)

filter

01 0.75MG/ML (1)

02 1,200MG;600MG;30,000UNITS (1)

03 1000MG/40ML (1)

04 100MG (4)

05 100MG/10ML (10MG/ML) (1)

06 100MG/ML (1)

07 100MG/VIAL (1)

08 105MG/0.7ML (1)

09 10MG/10ML(1MG/ML) (1)

10 10MG/2ML (5MG/ML) (3)

11 10MG/ML (1)

12 10MG/VIAL (1)

13 1200MG/20ML (2)

14 120MG/ML (2)

15 1400MG and 23400UNITS/11.7ML (1)

16 140MG/VIAL (1)

17 150MG (2)

18 150MG/ML (1)

19 150MG/VIAL (1)

20 1600MG and 26800UNITS/13.4ML (1)

21 160MG (1)

22 162MG/0.9ML (1)

23 1MG/ML (2)

24 2.5MG/2.5ML(1MG/ML) (1)

25 200MG (2)

26 200MG/10ML (1)

27 20MG (1)

28 20MG/2ML (10MG/ML) (2)

29 21MG/ML (1)

30 267MG (2)

31 2MG/ML (1)

32 2MG/VIAL (1)

33 300MG/2ML (1)

34 30MG/1ML (1)

35 30MG/30ML (1)

36 30MG/ML (1)

37 30MG/VIAL (1)

38 400MG (1)

39 400MG/20ML (1)

40 40MG (1)

41 420MG/14ML (1)

42 500MG/50ML (10MG/ML) (1)

43 50MG/PACKET (1)

44 50MG/VIAL (2)

45 534MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

46 5MG/2ML (2.5MG/ML) (1)

47 5MG/VIAL (1)

48 600MG;10000UNITS (1)

49 600MG;600MG;20,000UNITS (1)

50 60MG/0.4ML (1)

51 75MG/0.5ML (1)

52 801MG (1)

53 80MG (1)

54 80MG/4ML (1)

55 EQ 20MG BASE (1)

56 N/A (1)

filter

01 USA (69)

URL Supplier Web Content
VIAL; SINGLE-USE
100MG
KADCYLA
USA
125427
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
VIAL; SINGLE-USE
160MG
KADCYLA
USA
125427
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
VIAL; SINGLE-USE
100MG/VIAL
ACTIVASE
USA
103172
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
VIAL; SINGLE-USE
50MG/VIAL
ACTIVASE
USA
103172
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
VIAL
2MG/VIAL
CATHFLO ACTIVASE
USA
103172
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
INJECTABLE;INJECTION
1200MG/20ML
TECENTRIQ
USA
761034
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
INJECTABLE; INJECTION
1200MG/20ML
TECENTRIQ
USA
761041
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
20MG
XOFLUZA
USA
210854
2018-10-24
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
80MG
XOFLUZA
USA
210854
2021-03-18
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
FOR SUSPENSION;ORAL
2MG/ML
XOFLUZA
USA
214410
2020-11-23
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY